The present invention relates to sequence selective compounds for targeting therapeutic or diagnostic groups to polynucleotides. More particularly, the present invention relates to sequence selective targeting of metallocomplexes, such as metallodrugs and metallodiagnostics, to polynucleotides.
本发明涉及用于将治疗或诊断药物组选择性地定向到多核苷酸的序列选择性化合物。更具体地,本发明涉及将
金属配合物(如
金属药物和
金属诊断剂)的序列选择性定向到多核苷酸。